Skip to main content

Table 10 Difference in means between treatment and control groups for TG at final follow-up

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Author Sample size (treatment group vs. control group) Difference 95% CI
Cabral et al. [57] 32 (14 vs. 18) − 1.72 mmol/L* − 3.51 to 0.07
Caraccio et al. [58] 49 (24 vs. 25) − 0.10 mmol/L* − 0.46 to 0.26
Duman et al. [60] 39 (20 vs. 19) − 1.94 mmol/L* − 3.65 to − 0.24
Iqbal et al. [62] 64 (32 vs. 32) − 0.10 mmol/L* − 0.52 to 0.32
Liu et al. [64] 119 (60 vs. 59) − 0.08 mmol/L** − 0.26 to 0.10
Mikhail et al. [66] 120 (60 vs. 60) − 0.11 mmol/L* − 0.31 to 0.09
Monzani et al. [68] 45 (23 vs. 22) − 0.81 mmol/L* − 2.22 to 0.60
Nagasaki et al. [69] 95 (48 vs. 47) 0.12 mmol/L** − 0.17 to 0.41
Teixeira et al. [74, 75] 26 (11 vs. 15) − 0.98 mmol/L* − 3.52 to 1.55
  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group